Les cellules n’exprimant plus le gène suppresseur de tumeur RASSF1A, forment davantage des longs prolongements cytoplasmiques (TNTs), qu’elles soient …
Presenter: Rui-Hua Xu, MD, PhD Presenter: Aaron Elliott Lisberg, MD Presenter: Silver Alkhafaji, BS Discussant: Emil Lou, MD, PhD Discussant: Lillian L. Siu, MD, FASCO,…
There have been significant advances in colorectal cancer (CRC) immunotherapy over the past decade, with incorporation into both the metastatic and adjuvant/neoadjuvant treatment spaces. However,…
There have been significant advances in colorectal cancer (CRC) immunotherapy over the past decade, with incorporation into both the metastatic and adjuvant/neoadjuvant treatment spaces. However,…
Implementation of Treat-to-Target (T2T) in routine clinical practice remains low in systemic lupus erythematosus (SLE). Real-world data reveal excessi…
Key details about the program, registration, networking opportunities, and more, to help attendees prepare for the AACR Annual Meeting 2025.
Increasingly, the language of female reproduction is changing, so terms directly referencing people’s sex are replaced with terms obscuring sex, a lan…
Plants are composed of diverse secondary metabolites (PSMs), which are widely associated with human health. Whether and how the gut microbiome mediate…
Mitochondria appear to communicate and cooperate with one another, both within and between cells. Biologists are only just beginning to understand how and why.
Background In patients with colorectal cancer (CRC), the therapeutic effects of conventional immune checkpoint inhibitors targeting the adaptive immune system are largely limited to those…
Why are young people getting cancer at higher rates? No one knows, but here’s how to stay proactive and vigilant.
